Alphabet Forecast, price target & analysts
Alphabet Target price 2026 - Analyst rating & recommendation
Alphabet Classifications & Recommendation
Alphabet Price Target
| Target Price | $433.50 |
| Price | $317.28 |
| Potential | 36.63% |
| Number of Estimates | 58 |
| 58 Analysts have issued a price target Alphabet 2027 . The average Alphabet target price is $433.50. This is 36.63% higher than the current stock price. The highest price target is $540.75 70.43% , the lowest is $318.15 0.27% . | |
| A rating was issued by 70 analysts: 63 Analysts recommend Alphabet to buy, 7 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Alphabet stock has an average upside potential 2027 of 36.63% . Most analysts recommend the Alphabet stock at Purchase. |
Sales and Margin forecast 2026, 2027 to 2032
61 Analysts have issued a sales forecast Alphabet 2026 . The average Alphabet sales estimate is
. This is than the revenue of the last 12 months(TTM). The highest sales forecast is , the lowest is .This results in the following potential growth metrics:
54 Analysts have issued an Alphabet EBITDA forecast 2026. The average Alphabet EBITDA estimate is
. This is than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is , the lowest is .This results in the following potential growth metrics and future EBITDA Margins:
62 Alphabet Analysts have issued a net profit forecast 2026. The average Alphabet net profit estimate is
. This is than the net profit for the last 12 months(TTM). The highest net profit forecast is , the lowest is .This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2032
Current Alphabet Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Citizens |
Market Outperform
➜
Market Outperform
|
Unchanged | Oct 22 2026 |
| BMO Capital |
Outperform
➜
Outperform
|
Unchanged | Oct 20 2026 |
| Keybanc |
Overweight
➜
Overweight
|
Unchanged | Oct 19 2026 |
| JP Morgan |
Overweight
➜
Overweight
|
Unchanged | Oct 15 2026 |
| UBS |
Neutral
➜
Neutral
|
Unchanged | Oct 14 2026 |
| Cantor Fitzgerald |
Overweight
➜
Overweight
|
Unchanged | Oct 12 2026 |
| Needham |
Buy
➜
Buy
|
Unchanged | Oct 08 2026 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
Citizens:
Market Outperform
➜
Market Outperform
|
Oct 22 2026 |
|
Unchanged
BMO Capital:
Outperform
➜
Outperform
|
Oct 20 2026 |
|
Unchanged
Keybanc:
Overweight
➜
Overweight
|
Oct 19 2026 |
|
Unchanged
JP Morgan:
Overweight
➜
Overweight
|
Oct 15 2026 |
|
Unchanged
UBS:
Neutral
➜
Neutral
|
Oct 14 2026 |
|
Unchanged
Cantor Fitzgerald:
Overweight
➜
Overweight
|
Oct 12 2026 |
|
Unchanged
Needham:
Buy
➜
Buy
|
Oct 08 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
